Krystal Biotech buy Bank of America Co.
Start price
22.01.26
/
50%
€246.10
Target price
22.01.27
€272.02
Performance (%)
17.80%
Price
08:36
€289.90
Summary
This prediction is currently active. The prediction currently has a performance of 17.80%. This prediction currently runs until 22.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 1.518% | 1.518% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $288.00 to $318.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€129.30
22.07.25
22.07.25
€164.24
22.07.26
22.07.26
125.52%
23.07.26
23.07.26
